Cargando…

Patient registries for substance use disorders

This commentary discusses the need for developing patient registries of substance use disorders (SUD) in general medical settings. A patient registry is a tool that documents the natural history of target diseases. Clinicians and researchers use registries to monitor patient comorbidities, care proc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tai, Betty, Hu, Lian, Ghitza, Udi E, Sparenborg, Steven, VanVeldhuisen, Paul, Lindblad, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114906/ https://www.ncbi.nlm.nih.gov/pubmed/25114612 http://dx.doi.org/10.2147/SAR.S64977

Ejemplares similares

Expanding the National Drug Abuse Treatment Clinical Trials Network to address the management of substance use disorders in general medical settings
por: Tai, Betty, et al.
Publicado: (2014)

Privacy protection for patients with substance use problems
por: Hu, Lianne Lian, et al.
Publicado: (2011)

Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems
por: Ghitza, Udi E, et al.
Publicado: (2011)

Integrating substance abuse care with community diabetes care: implications for research and clinical practice
por: Ghitza, Udi E, et al.
Publicado: (2013)

Preventing deaths from rising opioid overdose in the US – the promise of naloxone antidote in community-based naloxone take-home programs
por: Straus, Michele M, et al.
Publicado: (2013)

NIDA Clinical Trials Network Common Data Elements Initiative: Advancing Big-Data Addictive-Disorders Research
por: Ghitza, Udi E., et al.
Publicado: (2015)

Needed Relapse-Prevention Research on Novel Framework (ASPIRE Model) for Substance Use Disorders Treatment
por: Ghitza, Udi E.
Publicado: (2015)

Selection and utilization of assessment instruments in substance abuse treatment trials: the National Drug Abuse Treatment Clinical Trials Network experience
por: Rosa, Carmen, et al.
Publicado: (2012)

ASPIRE Model for Treating Cannabis and Other Substance Use Disorders: A Novel Personalized-Medicine Framework
por: Ghitza, Udi E.
Publicado: (2014)

Overlapping Mechanisms of Stress-Induced Relapse to Opioid Use Disorder and Chronic Pain: Clinical Implications
por: Ghitza, Udi E.
Publicado: (2016)

Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes
por: Wu, Li-Tzy, et al.
Publicado: (2018)

Commentary: Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders
por: Ghitza, Udi E.
Publicado: (2017)

Commentary: Interaction of the ADRB2 Gene Polymorphism with Childhood Trauma in Predicting Adult Symptoms of Posttraumatic Stress Disorder
por: Ghitza, Udi E.
Publicado: (2015)

Commentary: A Gene-Based Association Method for Mapping Traits Using Reference Transcriptome Data
por: Ghitza, Udi E.
Publicado: (2016)

Screening, treatment initiation, and referral for substance use disorders
por: Bernstein, Steven L., et al.
Publicado: (2017)

The National Drug Abuse Treatment Clinical Trials Network: forging a partnership between research knowledge and community practice
por: Tai, Betty, et al.
Publicado: (2011)

Electronic health records: essential tools in integrating substance abuse treatment with primary care
por: Tai, Betty, et al.
Publicado: (2012)

A Commentary on “A New Initiative on Precision Medicine”
por: Ghitza, Udi E.
Publicado: (2015)

Commentary: Rewriting the Valuation and Salience of Alcohol-Related Stimuli via Memory Reconsolidation
por: Ghitza, Udi E.
Publicado: (2016)

Evolution of policy for the treatment of substance use disorders in Qatar
por: Alabdulla, Majid, et al.
Publicado: (2022)

Concomitant Cannabis Misuse and Associations with Depression, Pain and Substance Misuse among Patients Prescribed Opioids
por: Bryan, M. Aryana, et al.
Publicado: (2021)

Towards a framework for implementing physician education in substance use disorders
por: Klimas, Jan, et al.
Publicado: (2021)

School-based substance use disorder prevention in India: A brief appraisal
por: Pattojoshi, Amrit, et al.
Publicado: (2020)

Clinical epidemiology of substance use disorders: Understanding patterns, sharing knowledge, planning interventions
por: Mannelli, Paolo, et al.
Publicado: (2019)

Intrapartum Cesarean Delivery in Nulliparas: Risk Factors Compared by Two Analytical Approaches
por: Kominiarek, Michelle A., et al.
Publicado: (2014)

Developmental trajectory of substance use disorders: What role do the parents play (or are perceived to play)?
por: Basu, Debasish, et al.
Publicado: (2014)

Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence-based prediction, expert evaluation, clinical corroboration and mechanism of action analyses
por: Gao, Zhenxiang, et al.
Publicado: (2023)

Reducing Fear to Help Build Healthy Families: Investing in Non-Punitive Approaches to Helping People with Substance Use Disorder
por: Scott, Karen A., et al.
Publicado: (2023)

Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol
por: Mao, Yurong, et al.
Publicado: (2017)

Meeting people where they are: implementing hospital-based substance use harm reduction
por: Perera, Rachel, et al.
Publicado: (2022)

Prenatal Substance Use: Exploring Assumptions of Maternal Unfitness
por: Terplan, Mishka, et al.
Publicado: (2015)

The need for a new keyword — “Trial registry-metaresearch” — to track certain uses of clinical trial registry records
por: Saberwal, Gayatri
Publicado: (2023)

Navigating Minority and Gender Discrimination, Substance Use Disorder, Financial Distress, and Workplace Politics: Lessons for Work-Life Wellness in Academic Medicine: Part 2 of 3
por: Ahmed, Rami, et al.
Publicado: (2023)

Posttraumatic Stress Disorder in Children in the Context of the COVID-19 Pandemic
por: Pfefferbaum, Betty
Publicado: (2022)

Commentary on substance use disorders and risk of suicide in a general US population: a case control study by Lynch et al.
por: Little, Virna, et al.
Publicado: (2020)

The opioid overdose epidemic: opportunities for pharmacists
por: Wu, Li-Tzy, et al.
Publicado: (2017)

Substance abuse and rehabilitation: responding to the global burden of diseases attributable to substance abuse
por: Wu, Li-Tzy
Publicado: (2010)

Family substance use screening: less to hide, more to gain
por: Mannelli, Paolo, et al.
Publicado: (2016)

Machine‐Learning prediction of comorbid substance use disorders in ADHD youth using Swedish registry data
por: Zhang‐James, Yanli, et al.
Publicado: (2020)

Gastrin-releasing peptide, substance P and cytokines in rheumatoid arthritis
por: Green, Paul G
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_3kvi1o8i90ife8ghqt3q9s6ak6